N-Glycosylation can selectively block or foster different receptor-ligand binding modes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 07 12 2020
accepted: 17 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 15 12 2021
Statut: epublish

Résumé

While DNA encodes protein structure, glycans provide a complementary layer of information to protein function. As a prime example of the significance of glycans, the ability of the cell surface receptor CD44 to bind its ligand, hyaluronan, is modulated by N-glycosylation. However, the details of this modulation remain unclear. Based on atomistic simulations and NMR, we provide evidence that CD44 has multiple distinct binding sites for hyaluronan, and that N-glycosylation modulates their respective roles. We find that non-glycosylated CD44 favors the canonical sub-micromolar binding site, while glycosylated CD44 binds hyaluronan with an entirely different micromolar binding site. Our findings show (for the first time) how glycosylation can alter receptor affinity by shielding specific regions of the host protein, thereby promoting weaker binding modes. The mechanism revealed in this work emphasizes the importance of glycosylation in protein function and poses a challenge for protein structure determination where glycosylation is usually neglected.

Identifiants

pubmed: 33664400
doi: 10.1038/s41598-021-84569-z
pii: 10.1038/s41598-021-84569-z
pmc: PMC7933184
doi:

Substances chimiques

Hyaluronan Receptors 0
Polysaccharides 0
Receptors, Cell Surface 0
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5239

Références

J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Carbohydr Res. 2016 Jun 16;428:8-17
pubmed: 27108103
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Blood. 1998 May 1;91(9):3494-502
pubmed: 9558410
Cell. 1990 Jun 29;61(7):1303-13
pubmed: 1694723
Nat Immunol. 2008 Jun;9(6):593-601
pubmed: 18490910
J Biol Chem. 2006 Aug 11;281(32):23138-49
pubmed: 16682414
Sci Rep. 2017 Feb 22;7:43006
pubmed: 28223691
Mol Cell. 2004 Feb 27;13(4):483-96
pubmed: 14992719
J Biol Chem. 2003 Oct 31;278(44):43550-5
pubmed: 12928429
J Struct Biol. 2015 Aug;191(2):214-23
pubmed: 26066970
J Mol Biol. 2011 Mar 4;406(4):631-47
pubmed: 21216252
Biochim Biophys Acta. 1999 Dec 6;1473(1):4-8
pubmed: 10580125
Nat Struct Mol Biol. 2007 Mar;14(3):234-9
pubmed: 17293874
Trends Biochem Sci. 2015 Jul;40(7):351-9
pubmed: 26002999
Proteins. 2014 Nov;82(11):3079-89
pubmed: 25116630
Biochemistry. 1997 Sep 9;36(36):10846-56
pubmed: 9312273
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Oncogene. 2008 Jan 24;27(5):585-95
pubmed: 17684489
PLoS Comput Biol. 2017 Jul 17;13(7):e1005663
pubmed: 28715483
J Immunol. 1999 May 1;162(9):5058-61
pubmed: 10227973
Glycobiology. 2015 Dec;25(12):1323-4
pubmed: 26543186
ACS Biomater Sci Eng. 2019 Aug 12;5(8):3753-3765
pubmed: 31598545
Trends Biotechnol. 2004 Oct;22(10):524-30
pubmed: 15450746
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4334-9
pubmed: 25805821
Cell Mol Life Sci. 2014 Aug;71(16):3165-72
pubmed: 24337809
J Biol Chem. 2013 Feb 8;288(6):3907-17
pubmed: 23269669
J Chem Inf Model. 2017 Oct 23;57(10):2401-2406
pubmed: 28906114
Biophys J. 2013 Sep 3;105(5):1217-26
pubmed: 24010665
Clin Exp Immunol. 2010 Aug;161(2):233-41
pubmed: 20491786
J Mol Biol. 2004 Jul 16;340(4):869-79
pubmed: 15223327
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Nat Rev Cancer. 2004 Jul;4(7):528-39
pubmed: 15229478
Science. 1997 Oct 24;278(5338):672-5
pubmed: 9381175
Sci Rep. 2015 Mar 09;5:8926
pubmed: 25748215
J Med Chem. 2014 Mar 27;57(6):2714-25
pubmed: 24606063
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
J Exp Med. 1995 Aug 1;182(2):419-29
pubmed: 7543137
J Clin Invest. 1997 Sep 1;100(5):1217-29
pubmed: 9276740
J Cell Biol. 1998 Jan 26;140(2):431-46
pubmed: 9442118
Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45
pubmed: 12511867
Biophys J. 2013 Mar 5;104(5):961-3
pubmed: 23473476
Cancer Res. 1998 Aug 15;58(16):3736-42
pubmed: 9721887
J Exp Med. 1996 Mar 1;183(3):1119-30
pubmed: 8642254
Anal Bioanal Chem. 2012 Aug;404(2):373-88
pubmed: 22722744
J Biol Chem. 1998 Jan 2;273(1):338-43
pubmed: 9417085
Cancer Res. 1993 Mar 15;53(6):1262-8
pubmed: 8443806
J Phys Chem Lett. 2017 Mar 2;8(5):1060-1066
pubmed: 28191954
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nat Rev Mol Cell Biol. 2012 Jun 22;13(7):448-62
pubmed: 22722607
J Exp Med. 1995 Aug 1;182(2):431-7
pubmed: 7543138

Auteurs

Joni Vuorio (J)

Department of Physics, University of Helsinki, P.O. Box 64, 00014, Helsinki, Finland.
Computational Physics Laboratory, Tampere University, PO Box 692, 33014, Tampere, Finland.

Jana Škerlová (J)

Institute of Molecular Genetics, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.

Milan Fábry (M)

Institute of Molecular Genetics, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.

Václav Veverka (V)

Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, 128 00, Prague, Czech Republic.

Ilpo Vattulainen (I)

Department of Physics, University of Helsinki, P.O. Box 64, 00014, Helsinki, Finland.
Computational Physics Laboratory, Tampere University, PO Box 692, 33014, Tampere, Finland.
MEMPHYS-Centre for Biomembrane Physics, Odense, Denmark.

Pavlína Řezáčová (P)

Institute of Molecular Genetics, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.

Hector Martinez-Seara (H)

Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, 166 10, Prague 6, Czech Republic. hseara@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH